Stock 6118 AUSTAR LIFESCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Austar Lifesciences Limited Stock

Equities

6118

KYG0632L1023

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:05 2024-05-31 am EDT 		5-day change 1st Jan Change
0.82 HKD -4.65% Intraday chart for Austar Lifesciences Limited +2.50% -47.44%
Mar. 26 Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 22 Austar Lifesciences to Swing to Loss; Shares Drop MT

Financials

Sales 2022 2.23B 308M 2.41B Sales 2023 1.76B 244M 1.9B Capitalization 727M 100M 785M
Net income 2022 87M 12.01M 93.94M Net income 2023 -113M -15.6M -122M EV / Sales 2022 0.49 x
Net Debt 2022 188M 26.02M 203M Net Debt 2023 322M 44.53M 348M EV / Sales 2023 0.59 x
P/E ratio 2022
10.5 x
P/E ratio 2023
-6.4 x
Employees 1,610
Yield 2022 *
-
Yield 2023
-
Free-Float 26.46%
More Fundamentals * Assessed data

Chart Austar Lifesciences Limited

Dynamic Chart

Latest news about Austar Lifesciences Limited

Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Austar Lifesciences to Swing to Loss; Shares Drop MT
Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023 CI
Austar Lifesciences Hires New Auditor MT
Austar Lifesciences Swings to Loss in H1 MT
Austar Lifesciences Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
ValGenesis, Inc. and AUSTAR Group Partner to Deploy Digital, Risk-Based Solutions for Life Sciences Companies in China CI
Austar Lifesciences Expects Higher Loss in H1 MT
Austar Lifesciences Limited Updates Consolidated Group Earnings Guidance for the Six Months Ending June 30, 2023 CI
Austar Lifesciences Warns of H1 Loss MT
Austar Lifesciences Limited Provides Group Earnings Guidance for the Six Months Ending 30 June 2023 CI
Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Austar Lifesciences Expects 2022 Profit to Fall to 50 Million Yuan MT
Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022 CI
Austar Lifesciences Limited Announces Executive Changes CI
More news

Press releases Austar Lifesciences Limited

Austar Lifesciences Announces 2022 Annual Results AQ
Austar Lifesciences : PROPOSED GRANT OF GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING PU
Austar Lifesciences : 2020 Annual Report PU
Austar Lifesciences : MAJOR TRANSACTION - DISPOSAL OF 60% INTEREST IN PALL-AUSTAR JV PU
Austar Lifesciences : DELAY IN DESPATCH OF CIRCULAR IN RESPECT OF MAJOR TRANSACTION - DISPOSAL OF 60% INTEREST IN PALL-AUSTAR JV PU
More press releases

Quotes and Performance

1 day-4.65%
1 week+2.50%
1 month+7.89%
3 months-46.41%
6 months-56.84%
Current year-47.44%
More quotes

Highs and lows

1 week
0.75
Extreme 0.75
0.88
1 month
0.70
Extreme 0.7
1.06
Current year
0.70
Extreme 0.7
2.20
1 year
0.70
Extreme 0.7
3.18
3 years
0.70
Extreme 0.7
30.90
5 years
0.70
Extreme 0.7
30.90
10 years
0.67
Extreme 0.67
30.90
More quotes

Managers and Directors - Austar Lifesciences Limited

Managers TitleAgeSince
Kwok Keung Ho CEO
 Chief Executive Officer 61 14-01-08
Yuk Kiu Mak SEC
 Corporate Secretary - 22-09-30
Xiang Di Tang PRN
 Corporate Officer/Principal 47 -
Members of the board TitleAgeSince
Lap Kei Cheung BRD
 Director/Board Member 52 14-10-20
Oi Kin Leung BRD
 Director/Board Member 50 17-10-20
Kwok Keung Ho CEO
 Chief Executive Officer 61 14-01-08
More insiders

Quotes

Date Price Change Volume
24-05-31 0.82 -4.65% 37,000
24-05-30 0.86 +7.50% 1,000
24-05-29 0.8 -1.23% 50,000
24-05-28 0.81 -1.22% 25,000
24-05-27 0.82 +2.50% 48,000

Delayed Quote Hong Kong S.E., May 31, 2024 at 04:08 am EDT

More quotes

Company Profile

Austar Lifesciences Limited is principally engaged in the provision of integrated engineering solutions to pharmaceutical manufactures and research institutes and the manufacture and distribution of pharmaceutical equipment and consumables in China. The Company operates its business through six segments: liquid and bioprocess system segment, clean room and automation control and monitoring system segment, powder and solid system segment, good manufacturing practice (GMP) compliance service segment, life science consumables segment and distribution and agency of pharmaceutical equipment segment.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-08-25 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
AUSTAR LIFESCIENCES LIMITED Stock Austar Lifesciences Limited
-47.44% 53.75M
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.16% 178B
MEDTRONIC PLC Stock Medtronic plc
-1.23% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.86% 67.04B
DEXCOM, INC. Stock DexCom, Inc.
-4.28% 47.23B
CENCORA, INC. Stock Cencora, Inc.
+10.32% 44.62B
HOYA CORPORATION Stock Hoya Corporation
+8.14% 42.5B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.76% 29.99B
TERUMO CORPORATION Stock Terumo Corporation
+15.53% 25.22B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.88% 24.14B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 6118 Stock